Statistics for From proteomics to discovery of first-in-class ST2 inhibitors active in vivo
Total visits
views | |
---|---|
From proteomics to discovery of first-in-class ST2 inhibitors active in vivo | 169 |
Total visits per month
views | |
---|---|
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
File Visits
views | |
---|---|
jciinsight-3-99208.pdf | 171 |
java.util.UUID:c14ebf31-0c4b-40cb-8b29-39b31f5c00ea | 41 |
java.util.UUID:71b4b9ed-5254-416f-af6f-867c70f86d53 | 16 |
java.util.UUID:b8521bf1-a759-41cd-9205-72c1a86ce340 | 10 |
Top country views
views | |
---|---|
United States | 122 |
Germany | 9 |
Ukraine | 6 |
China | 3 |
United Kingdom | 3 |
Sweden | 3 |
Canada | 2 |
Russia | 2 |
Vietnam | 2 |
Switzerland | 1 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 52 |
Fairfield | 20 |
Houston | 7 |
Jacksonville | 6 |
Kiez | 6 |
Kiev | 5 |
San Francisco | 3 |
Stockholm | 3 |
Ann Arbor | 2 |
Cambridge | 2 |
Dong Ket | 2 |
Gunzenhausen | 2 |
Lake Mary | 2 |
Toronto | 2 |
Azusa | 1 |
Baltimore | 1 |
Beijing | 1 |
Brooklyn | 1 |
Changsha | 1 |
Cointrin | 1 |
Costa Mesa | 1 |
Frankfurt Am Main | 1 |
Indianapolis | 1 |
Kharkov | 1 |
Saint Petersburg | 1 |
Scottsdale | 1 |
Seremban | 1 |